JESSICA BAXTER: Open Payments
NPI 1215372479 · GEORGETOWN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 10 payments from 7 companies in 2025. Trend: 2023 $104 · 2024 $112 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Lilly USA, LLC | 2 | $33 |
| Exact Sciences Corporation | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
Products named: BREZTRI, MOUNJARO, The Cologuard Plus Collection Kit, QULIPTA, TRELEGY ELLIPTA, GEMTESA, Ozempic, VRAYLAR.
Industry payments across DE — which companies pay providers there.
